Could decentralised trials transform the way we view depression? Could decentralised trials transform the way we view depression? Could decentralised trials transform the way we view depression? Dr Vikas Mohan Sharma believes this could deliver meaningful changes for patients all arround.
First half 2019: High levels of investment in R&D and robust organic growth First half 2019: High levels of investment in R&D and robust organic growth First half 2019: High levels of investment in R&D and robust organic growth
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D Good business performance gives Boehringer Ingelheim tailwind for investment in R&D Good business performance gives Boehringer Ingelheim tailwind for investment in R&D